Hypertrophic Cardiomyopathy Secondary to RAF1 Cysteine-Rich Domain Variants.

Authors :: Fullenkamp DE
Jorgensen RM
Leach DF
Sinha A
Salamone IM
Johnston JR
Dellefave-Castillo LM
Choudhury L
McNally EM
Wilsbacher LD
Source :: Circulation. Genomic and precision medicine [Circ Genom Precis Med] 2023 Dec; Vol. 16 (6), pp. e004262. Date of Electronic Publication: 2023 Oct 31.
Publication Year :: 2023
Abstract: Competing Interests: Disclosures Dr McNally is or was a consultant for Amgen, AstraZeneca, Avidity, Cytokinetics, Pfizer, PepGen, Stealth Biopharma, Tenaya, and Invitae. She is the founder of Ikaika Therapeutics, Inc. These relationships are unrelated to this article.